Loading viewer...
investor_presentation
Format: PDF investor_presentation
Hyloris Pharmaceuticals SA is a Belgium-based pharmaceutical company reformulating and repurposing existing chemical entities to address unmet medical needs. The company focuses on value-added cardiovascular and other therapeutic assets through lower-risk development approaches, with a growing portfolio of 30 assets and operations on Euronext Brussels.
investor_presentation
19 Pages
Live Ventures Incorporated